(Q37814575)

23 August 2017

1 reference

title

Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation (English)

1 reference

23 August 2017

0 references

George S. Abela

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21122648

19 November 2024

language of work or name

English

0 references

publication date

16 March 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1933287410001029?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

https://api.elsevier.com/content/article/PII:S1933287410001029?httpAccept=text/plain

19 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Journal of Clinical Lipidology

19 November 2024

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

156-164

1 reference

Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study

23 August 2017

cites work

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1161/01.CIR.0000025609.13806.31

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Inflammation in atherosclerosis

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Cholesterol crystals cause mechanical damage to biological membranes: a proposed mechanism of plaque rupture and erosion leading to arterial thrombosis.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events--a novel insight into plaque rupture by scanning electron microscopy

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Chemical composition and physical state of lipid deposits in atherosclerosis

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

C-reactive protein levels and outcomes after statin therapy

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Inflammatory biomarkers in stable atherosclerosis

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Inflammatory markers and coronary artery disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Type of alcoholic beverage and first acute myocardial infarction: a case-control study in a Mediterranean country.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Alcohol and cardiovascular health: the razor-sharp double-edged sword

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Meta-analysis of wine and beer consumption in relation to vascular risk

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Alcohol consumption and plasma concentration of C-reactive protein

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Genetic factors influencing lipoprotein structure: implications for atherosclerosis

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

A receptor-mediated pathway for cholesterol homeostasis

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Development of the lipid-rich core in human atherosclerosis

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and rupture

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Intraplaque hemorrhage and progression of coronary atheroma

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

19 November 2024

Intraplaque hemorrhage

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Cholesterol crystals as an etiological factor in non-resolving chronic inflammation: an experimental study in guinea pigs

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Physical factors that trigger cholesterol crystallization leading to plaque rupture

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

AN X-RAY-DIFFRACTION STUDY OF CRYSTALLINE CHOLESTEROL IN SOME PATHOLOGICAL DEPOSITS IN MAN

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Seasonality and daily weather conditions in relation to myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, 1979 to 2002.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Atherosclerotic plaque caps are locally weakened when macrophages density is increased

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Carotid atherosclerotic plaque instability in patients with acute myocardial infarction

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Angioscopically-determined extent of coronary atherosclerosis is associated with severity of acute coronary syndrome

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Atherosclerotic plaque rupture: local or systemic process?

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Multiple plaque rupture and C-reactive protein in acute myocardial infarction

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Insights into the role of infection in atherogenesis and in plaque rupture

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Optimized THP-1 differentiation is required for the detection of responses to weak stimuli.

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Deposition and aggregation of aspirin molecules on a phospholipid bilayer pattern

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

High-dose atorvastatin after stroke or transient ischemic attack

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Advances in the molecular genetics of corneal dystrophies

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

The cornea and disorders of lipid metabolism

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Gout-associated uric acid crystals activate the NALP3 inflammasome

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

The incidence of alkaptonuria: a study in chemical individuality. 1902 [classical article]

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

Natural history of alkaptonuria

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACL.2010.03.003

19 November 2024

Identifiers

DOI

1 reference

23 August 2017

1 reference